Viewing Study NCT03184168


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-02-02 @ 6:11 AM
Study NCT ID: NCT03184168
Status: COMPLETED
Last Update Posted: 2017-09-12
First Post: 2017-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None healthy volunteers, lorlatinib, PF-06463922, ADME, NSCLC, radiolabel, metabolism View